Integration completed, with focus shifting to growth, technology, and care quality. Q2 2025 saw 7.3% revenue growth, strong member additions, and improved cost discipline despite one-off provisions. Outlook remains positive with new products, robust pipelines, and continued deleveraging.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.